CS logo
small CS logo
Gadolin Research, LLC

Beaumont, Texas, United States
Doctor in Beaumont, Texas
2965 Harrison Ave STE 320, Beaumont, TX 77702

About Gadolin Research, LLC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
6
Pfizer
2
Abbott Nutrition
1
Arena Pharmaceuticals
1
Astellas Pharma Global Development, Inc.
1
Bayer
1
Evofem Inc.
1
Hoffmann-La Roche
1
Supernus Pharmaceuticals, Inc.
1
Total Rows: 9

Clinical Trials at Gadolin Research, LLC


During the past decade, Gadolin Research, LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years331144331133000000222233Started TrialsCompleted Trails2017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2B/3 Double-blinded Placebo-controlled
2017-11-03
2019-08-22
Completed
860
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
2017-03-29
2019-06-11
Terminated
806
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD
2017-11-20
2019-02-14
Completed
297
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
2018-01-24
2021-06-30
Terminated
103
A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause
2019-07-10
2022-01-04
Completed
1,831
A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN
2019-08-07
2021-09-30
Completed
1,153
Growth and Tolerance of Young Infants Fed Infant Formula
2019-09-30
2020-12-04
Completed
366
A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
2019-10-04
2021-10-11
Completed
140

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Gadolin Research, LLC" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored, "Arena Pharmaceuticals" with 1 trials sponsored and "Astellas Pharma Global Development, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gadolin Research, LLC" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "Clinical Research Management, Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator and "Vir Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 6Eli Lilly and Company: 6Pfizer: 2Pfizer: 2Abbott Nutrition: 1Abbott Nutrition: 1Arena Pharmaceuticals: 1Arena Pharmaceuticals: 1Astellas Pharma GlobalDevelopment, Inc.: 1Astellas Pharma GlobalDevelopment, Inc.: 1Bayer: 1Bayer: 1Evofem Inc.: 1Evofem Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1SupernusPharmaceuticals, Inc.: 1SupernusPharmaceuticals, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAbCellera Biologics Inc.: 1AbCellera Biologics Inc.: 1Clinical ResearchManagement, Inc.: 1Clinical ResearchManagement, Inc.: 1GlaxoSmithKline: 1GlaxoSmithKline: 1Shanghai JunshiBioscience Co., Ltd.: 1Shanghai JunshiBioscience Co., Ltd.: 1Vir Biotechnology, Inc.: 1Vir Biotechnology, Inc.: 1

Clinical Trials Conditions at Gadolin Research, LLC


According to Clinical.Site data, the most researched conditions in "Gadolin Research, LLC" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Respiratory Tract Infection" (2 trials), "ADHD" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Gadolin Research, LLC" in a lesser frequency.

Clinical Trials Intervention Types at Gadolin Research, LLC


Most popular intervention types in "Gadolin Research, LLC" are "Drug" (12 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Donanemab" (2 trials), "400mg SPN-812" (1 trials), "600mg SPN-812" (1 trials) and "Bamlanivimab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Gadolin Research, LLC


The vast majority of trials in "Gadolin Research, LLC" are 10 trials for "All" genders and 5 trials for "Female" genders.

Clinical Trials Status at Gadolin Research, LLC


Currently, there are NaN active trials in "Gadolin Research, LLC". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Gadolin Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Gadolin Research, LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 4Phase 2: 4Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Active, not recruiting: 4Active, not recruiting: 4Recruiting: 2Recruiting: 2Terminated: 2Terminated: 2